The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies

Molecular Psychiatry

Volumn 1, Issue 6, 1996, Pages 445-452

  Magistretti, P J ^a,b   Pellerin, L ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Brain energy metabolism; Brain imaging; Depression; Eating disorders; Schizophrenia

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORINE;

ASTROCYTE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOLOGY; HUMAN; MENTAL DISEASE; METABOLISM; METHODOLOGY; REVIEW;

ASTROCYTES; BRAIN; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; HUMANS; MENTAL DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030320546     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Raichle ME. Visualizing the mind. Sci Am 1994; 270: 36-42.
2. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
3. Raichle ME. Quantitative in vivo autoradiography with positron emission tomography. Brain Res Rev 1979; 1: 47-68.
4. Reivich M, Alavi A. Positron emission tomographic studies of local cerebral glucose metabolism in humans in physiological and pathophysiological conditions. Adv Metab Dis 1983; 10: 135-176.
5. 18F-fluoro-deoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979; 44: 127-137.
6. 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr 1980; 4: 727-736.
7. 15O. II. Implementation and validation. J Nucl Med 1983; 24: 790-798.
8. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, Ugurbil K. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992; 89: 5951-5955.
9. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R, Cheng H-M, Brady TJ, Rosen BR. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 1992; 89: 5675-5679.
10. Cohen MS, Bookheimer SY. Localization of brain function using magnetic resonance imaging. Trend Neurosci 1994; 17: 268-277.
11. Villringer A, Dirnagl U. Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovasc Brain Metab Rev 1995; 7: 240-276.
12. Wiesel F-A. Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies? J Neural Transm 1992; 37: 1-18.
13. Volkow ND, Fowler JS. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse. Seminars Nucl Med 1992; 22: 254-267.
14. Buchsbaum MS. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness. Clin Neurosci 1995; 3: 122-130.
15. Ingvar DH, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974; 50: 425-462.
16. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11: 184-190.
17. Baxter LR, Phelps ME, Maziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 1985; 42: 441-447.
18. Wolfson LI, Leenders KL, Brown LL, Jones T. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 1985; 35: 1399-1405.
19. Goffinet AM, Voider AG de, Gillain C, Rectem D, Bol A, Michel C, Cogneau M, Labar D, Laterre C. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol 1989; 25: 131-139.
20. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JJ, Manning RG, Flynn RM, Mann LS, Bunney WE Jr, Sokoloff L. Cerebral glucography with positron tomography: use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982; 39: 251-259.
21. Wiesel F-A, Wik G, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatr Scand 1987; 76: 628-641.
22. Buchsbaum M, Haier R, Potkin S, Nuechterlein K, Bracha S, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek P, Trenary M, Tafalla R, Reynolds C, Bunney W. Frontostriatal disorder of cerebral metabolism in never medicated schizophrenics. Arch Gen Psychiatry 1992; 49: 935-942.
23. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985; 142: 564-571.
24. Cohen RM, Semple WE, Gross M, Nordahl TE, Holcomb HH, Dowling S, Pickar D. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sci 1988; 43: 1141-1150.
25. Wik G, Wiesel F-A, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S. Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacology 1989; 97: 309-318.
26. Bartlett EJ, Wilkin A, Brodie JD, Laska EM, Wolf AP. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia. Psychiatry Res: Neuroimaging 1991; 40: 115-124.
27. Buchsbaum MS, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, Marshall JF, Lottenberg S, Tang CY, Abel L, Pion L, Bunney WE Jr. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992; 49: 966-974.
28. Wolkin A, Angrist B, Wolf A, Brodie J, Wolkin B, Jaeger J, Cancro R, Rotrosen J. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology 1987; 92: 241-246.
29. Cleghorn JM, Garnett ES, Nahmias G, Firnau G, Brown GM, Kaplan R, Szechtman H, Szechtman B. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res 1989; 28: 119-133.
30. Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP. Acute D-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization clinical symptomatology. Biol Psychiatry 1994; 36: 317-325.
31. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 243-250.
32. Cohen RM, Semple WE, Gross M, Nordahl TD, King AC, Pickar D, Post RM. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989; 2: 241-254.
33. Martinot JL, Allilaire JF, Mazoyer BM, Hantouche E, Huret JD, Legaut-Demare F, Deslauriers AG, Hardy P, Pappata S, Baron JC, Syrota A. Obsessive-compulsive disorder: a clinical neuropsychological and positron emission tomography study. Acta Psychiatr Scand 1990; 82: 233-242.
34. Martinot JL, Hardy P, Feline A, Hure JD, Mazoyer B, AttarLevy D, Pappata S, Syrota A. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990; 147: 1313-1317.
35. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 1985; 42: 441-447.
36. 18F]2-deoxyglucose in affective illness. J Affect Dis 1986; 10: 137-152.
37. Reiman EM, Raichle ME, Robins E, Butler FK, Herscovitch P, Fox P, Perlmutter J. The application of positron emission tomography to the study of panic disorder. Am J Psychiatry 1986; 143: 469-477.
38. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SL, Rapoport JL. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46: 518-523.
39. Kety SS. Circulation and metabolism in the human brain in health and disease. Am J Med 1950: 8: 205-217.
40. Reiman EM, Fusselman MJ, Fox PT, Raichle ME. Neuroanatomical correlates of anticipatory anxiety. Science 1989; 243: 1071-1074.
41. Baxter LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 1987; 44: 211-219.
42. Baxter LR, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, Fairbanks L. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145: 1560-1563.
43. Benkelfat C, Nordahl TD, Semple WE, King C, Murphy DL, Cohen RM. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 1990; 47: 840-848.
44. Herholz K, Krieg JC, Emrich HM, Pawlik G, Beil C, Pirke KM, Pahl JJ, Wagner R, Wienhard K, Ploog D, Heiss W-D. Regional cerebral glucose metabolism in anorexia nervosa measured by positron emission tomography. Biol Psychiatry 1987; 22: 43-51.
45. 18F-fluorodeoxyglucose method and positron emission tomography. In: 17th Congress of Collegium Internationale NeuroPsychopharmacologicum. Kyoto, Japan, 1990, p 330.
46. Hagman JO, Buchsbaum MS, Wu JC, Rao SJ, Reynolds CA, Blinder BJ. Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography. J Affect Dis 1990; 19: 153-162.
47. Wu JC, Hagman J, Buchsbaum MS, Blinder BJ, Derrfler M, Tai WT, Hazlett E, Sicotte N. Greater left cerebral hemispheric metabolism in bulimia assessed by positron emission tomography. Am J Psychiatry 1990; 147: 309-312.
48. 11C-glucose. Acta Psychiatr Scand 1988; 78: 234-241.
49. Magistretti PJ, Pellerin L. Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cerebral Cortex 1996; 6: 50-61.
50. Kadekaro M, Crane MA, Sokoloff L. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc Natl Acad Sci USA 1985; 82: 6010-6013.
51. Sokoloff L. Relationship between functional activity and energy metabolism in the nervous system: whether, where and why? In: Lassen NA, Ingvar DH, Raichle ME, Friberg L (eds). Brain Work and Mental Activity. Munksgaard: Copenhagen, 1991, p 52.
52. 14C]deoxyglucose technique. Proc Natl Acad Sci USA 1976; 73: 4230-4234.
53. Zeki S, Watson JDG, Lueck CJ, Friston KJ, Kennard C, Frackowiak RSJ. A direct demonstration of functional specialization in human visual cortex. J Neurosci 1991; 11: 641-649.
54. Deiber MP, Pollak P, Passingham R, Landais P, Gervason C, Cinotti L, Friston K, Frackowiak RSJ, Mauguière F, Benabid AL. Thalamic stimulation and suppression of parkinsonian tremor. Brain 1993; 116: 267-279.
55. O'Kusky J, Colonnier M. A laminar analysis of the number of neurons, glia and synapses in the visual cortex (area 17) of the adult macaque monkey. J Comp Neurol 1982; 210: 278-290.
56. Kimelberg HK, Norenberg MD. Astrocytes. Sci Am 1989; 260: 44-52.
57. Bignami A. Glial cells in the central nervous system. In: Magistretti PJ (ed). Discussions in Neuroscience, vol 8. Elsevier: Amsterdam, 1991, pp 1-45.
58. Tower DB, Young OM. The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J Neurochem 1973: 20: 269-278.
59. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16: 877-885.
60. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 1994; 91: 10625-10629.
61. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 1984; 42: 1-11.
62. Danbolt NC. The high affinity uptake system for excitatory amino acids in the brain. Prog Neurobiol 1994; 44: 377-396.
63. Pearce B. Amino acid receptors. In: Murphy S (ed). Astrocytes: Pharmacology and Function. Academic Press: San Diego,1993, pp 47-66.
64. Takahashi S, Driscoll BF, Law MJ, Sokoloff L. Role of sodium and potassium ions in regulation of glucose metabolism in cultured astroglia. Proc Natl Acad Sci USA 1995; 92: 4616-4620.
65. Barres BA. New roles for glia. J Neurosci 1991; 11: 3685-3694.
66. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW. Localization of neuronal and glial glutamate transporters. Neuron 1994; 13: 713-725.
67. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitoxicity and clearance of glutamate. Neuron 1996; 16: 675-686.
68. Kanner BI. Glutamate transporters from brain: a novel neurotransmitter transporter family. FEBS Lett 1993; 325: 95-99.
69. Kanai Y, Smith CP, Hediger MA. A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J 1994; 8: 1450-1459.
70. Bouvier M, Szatkowski M, Amato A, Atwell D. The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature 1992; 360: 471-474.
71. Bowman CL, Kimelberg HK. Excitatory amino acids directly depolarize rat brain astrocytes in primary culture. Nature 1984; 311: 656-659.
72. Kimelberg HK, Jalonen T, Walz W. Regulation of brain microenvironment: transmitters and ions. In: Murphy S (ed). Astrocytes: Pharmacology and Function. Academic Press: San Diego, 1993, pp 193-228.
73. + ATPase. Dev Neurosci 1996 (in press).
74. Mata M, Fink DJ, Gainer H, Smith CB, Davidsen L, Savaki H, Schwartz WJ, Sokoloff L. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem 1980; 34: 213-215.
75. McIlwain H. Substances which support respiration and metabolic: response to electrical impulses in human cerebral tissues. J Neurol Neurosurg Psychiatry 1953; 16: 257-266.
76. McIlwain H, Bachelard HS. Biochemistry and the Central Nervous System. Churchill Livingstone: New York, 1985, pp 54-83.
77. Schurr A, West CA, Rigor BM. Lactate-supported synaptic function in the rat hippocampal slice preparation. Science 1988; 240: 1326-1328.
78. Walz W, Muckerji S. Lactate release from cultured astrocytes and neurons: a comparison. Glia 1988; 1: 366-370.
79. 1H NMR in human visual cortex during physiologic: stimulation. Med Sci 1991; 88: 5829-5831.
80. 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1992; 12: 584-592.
81. Hossmann KA, Linn F. Regional energy metabolism during functional activation of the brain. J Cereb Blood Flow Metab 1907; 7: S297-S298.
82. Ueki M, Linn F, Hossmann KA. Functional activation of cerebral blood flow and metabolism before and after global ischemia of rat brain. J Cereb Blood Flow Metab 1988; 8: 486-494.
83. Dringen R, Wiesinger H, Hamprecht B. Uptake of L-lactate by cultured rat brain neurons. Neurosci Lett 1993; 163; 5-7.
84. Pellegri G, Bittar PG, Martin J-L, Magistretti PJ. Differential distribution of lactate transporters and lactate dehydrogenase (LDH) isozymes: evidence for an astrocyte-neuron lactate cycle. Soc Neurosci Ahstr 1996; 22 (in press).
85. Pardridge WM, Oldendorf WH. Transport of metabolic substrates through the blood-brain barrier. J Neurochem 1977; 28: 5-12.
86. Cahn RD, Kaplan NO, Levine L, Zwilling E. Nature and development of lactic dehydrogenases. Science 1962; 136: 962-969.
87. Dawson DM, Goodfriend TL, Kaplan NO. Lactic dehydrogenases: functions of the two types. Science 1964; 143: 929-933.
88. Bittar PG, Charnay Y, Pellerin L, Bouras C, Magistretti PJ. Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of the human brain. J Cereb Blood Flow Metab 1996 (in press).
89. Schatzberg AF, Schildkraut JJ. Recent studies on norepinephrine systems in mood disorders. In: Blom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, 1995, pp 911-920.
90. Yu N, Martin JL, Stella N, Magistretti PJ. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc Natl Acad Sci USA 1993; 90: 4042-4046.
91. Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 1986; 83: 1140-1144.
92. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988; 241: 462-464.